Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Predicted Market Size Of The Research-Grade Proteins Industry By 2029?

In recent times, there has been a massive expansion in the market size of research-grade proteins. The market size, which was at $1.11 billion in 2024, is projected to grow up to $1.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 20.4%. The significant upsurge in the previous period is a direct result of numerous influencing factors such as enhanced research activities, a surge in R&D operations in the pharmaceutical and biotech sectors, the escalating demand for personalized treatments, increased financial support from government bodies and educational institutions, and strategic acquisitions and collaborations.

In forthcoming years, the market for research-grade proteins is anticipated to expand at a brisk pace, reaching a valuation of $2.74 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 19.7%. This predicted growth trend over the forecast period is linked to factors such as the advancement in proteomics research, an increasing number of clinical trials, the incorporation of AI and data analytics, industrial applications of research-grade proteins, and a surge in demand for sophisticated research tools. The forecast period is also expected to witness key trends like increasing cognizance about groundbreaking technologies, forward strides in the biotechnology field, progress in proteomics and genomics, broadening applications in drug development, and evolved research tools’ use in biotechnology and pharmaceutical sectors.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15917&type=smp

Which Growth Drivers Are Shaping The Research-Grade Proteins Market Outlook?

The escalating count of clinical trials is projected to fuel the expansion of the research-grade proteins market. Clinical trials imply research studies that explore the efficacy and safety of new therapeutic interventions, medical devices, or treatments in human subjects. There’s a surge in the count of clinical trials owing to advancements in medical research, industry investment, regulatory amendments, the burden of disease, and patient demand. Research-grade proteins play a pivotal role in clinical trials as they are indispensable for tasks such as biomarker development, quality control, drug target identification, assay development, and establishing reference standards, thereby guaranteeing the reliability and precision of experimental results. For example, data from ClinicalTrials.gov, a US-based clinical trial database, indicates that by the cessation of 2023, the number of registered clinical trials worldwide on ClinicalTrials.gov had surged to 477,234, signifying an increase from 437,512 recorded trials in 2022. Consequently, the escalation in the number of clinical trials is stoking the growth of the research-grade proteins market.

How Does The Research-Grade Proteins Market Differ By Segment?

The research-grade proteins market covered in this report is segmented –

1) By Product: Cytokines And Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Host Cell: Mammalian Cells, Bacterial Cells, Fungi And Yeast, Insect Cells, Other Host Cells

3) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Other End-Uses

Subsegments:

1) By Cytokines And Growth Factors: Interleukins, Interferons, Colony Stimulating Factors, Erythropoietin, Granulocyte Macrophage Colony-Stimulating Factor

2) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Conjugated Antibodies

3) By Immune Checkpoint Proteins: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: HIV Antigens, Hepatitis Antigens, Influenza Antigens, Hepatitis B Antigens

5) By Enzymes: Restriction Enzymes, Proteases, Ligases, Kinases

6) By Recombinant Regulatory Proteins: Transcription Factors, Regulatory Enzymes, Epigenetic Modifiers

7) By Hormones: Insulin, Thyroid Hormones, Growth Hormones, Adrenaline

8) By Other Products: Peptides, Serum Proteins, Antigen-Binding Proteins

What New Opportunities Are Emerging From Trends In The Research-Grade Proteins Market?

Major firms in the research-grade proteins sector are creating Cas9 proteins to increase their effectiveness and usefulness in genome editing and various biotech applications. Cas9 proteins assist genome editing by functioning as molecular scissors capable of slicing DNA at specific points specified by a guide RNA (gRNA). For instance, Thermo Fisher Scientific Inc., a prominent biotechnology firm based in the USA, launched a state-of-the-art GMP-manufactured Gibco CTS TrueCut Cas9 Protein in April 2022. This superior, clinically compliant Cas9 protein is produced under the strict guidelines of Good Manufacturing Practice (GMP). This product is specifically manufactured for genome editing applications, ensuring optimal purity and performance for precise CRISPR-based research thus enabling progress in genetic engineering and treatment development.

Which Firms Are Making The Biggest Impact In The Research-Grade Proteins Market?

Major companies operating in the research-grade proteins market are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Bio-Techne, Stemcell Technologies Inc., Miltenyi Biotec, GenScript Biotech Corporation, Sino Biological Inc., ACROBiosystems, OriGene Technologies Inc., RayBiotech Inc., Rockland Immunochemicals Inc., Proteintech Group Inc., Novus Biologicals LLC, Active Motif, Aviva Systems Biology Corporation, StressMarq Biosciences Inc., Abnova Corporation, AnaSpec, Biomatik, Prospec-Tany Technogene Ltd., Cusabio Technology LLC, United States Biological, Laurus Bio, Boster Biological Technology, AMS Biotechnology Europe Ltd (AMSBIO)

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/research-grade-proteins-global-market-report

Which Region Is Leading Innovation In The Research-Grade Proteins Market?

North America was the largest region in the research-grade proteins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the research-grade proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15917&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model